期刊文献+

冠心病患者脂蛋白相关磷脂酶A2基因多态性研究 被引量:7

Connecting research to lipoprotein-associated phospholipaseA2 gene polymorphisms of the patients with coronary heart disease
原文传递
导出
摘要 目的探讨脂蛋白相关磷脂酶A2基因R92H和A379V多态性位点与冠心病遗传易感性的关系。方法采用单荧光标记探针技术检测261例冠心病患者、263例正常对照者脂蛋白相关磷脂酶A2基因R92H和A379V基因型。结果(1)92H等位基因携带者患冠心病的风险是92R等位基因携带者的1.75倍(P〈0.01);(2)冠心病组中单倍型379A92H的频率分布显着高于对照组(P〈0.01);(3)Logistic回归分析提示,R92H位点等位基因92H是冠心病的独立危险因素。结论脂蛋白相关磷脂酶A2基因R92H多态性与汉族人冠心病遗传易感性独立相关。 Objectives To investigate the association between R92H and A379V point mutation of lipoprotein-associated phospholipaseA2 (Lp-PLA2) and the patients with coronary heart disease, Methods 261 CHD patients and 263 normal controls were genotyped by using single-labeled probe technique. Results Compared with RR genotype, the relative risk for CHD in people with RH genotypes was 1.77 ( P 〈0.01 ). The relative risk for CHD in people with 92R allele was 1.75 higher than 92H allele (P 〈 0.01 ). The two polyn, orphisms of the LP-PLA2 gene were in strong linkage disequilibrium (LD). The frequency of the haplotype 379A92H was significantly (P 〈 0.01 ) higher in CHD patients than normal controls. When allied-gene analysis was performed for RR and AV genotype ,the risk of coronary heart disease was markedly reduced 46% (0R = 0.54), Binamy logistic regression analysis showed that polymorphism of R92H was an independent risk factor for CHD. Conclusion The polymorphism of R92H of Lp-PLA2 gene could be associated with risk of CHD in Han Chinese.
出处 《临床内科杂志》 CAS 2009年第1期18-20,共3页 Journal of Clinical Internal Medicine
基金 江苏省常州市卫生局重大招标项目(ZD200709)
关键词 脂蛋白相关磷脂酶A2 基因 多态性 冠心病 Lipoprotein-associated Phospholipase A2 Gene Polymorphism Coronary Heart Disease
  • 相关文献

参考文献10

  • 1Gerber Y, McConnell JP, Jaffe AS, et al. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community. Arteriosclerosis, thrombosis, and vascular biology, 2006, 26 : 2517-2522.
  • 2Garza CA, Montofi VM, McConnell JP, et al. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease:a systematic review. Mayo Clinic proceedings,2007,82 : 159-165.
  • 3Ninio E, Tregouet D, Carrier JL, et al. Platelet-activating factor-acetyl- hydrolase and PAF-receptor gene haplotypes in relation to future cardlo- vascular event in patients with coronary artery disease. Human molecular genetics ,2004,13 : 1341-1351.
  • 4罗光华,郑璐,张晓膺,许国锋,朱江,牟琴峰,魏江,陈陆俊,张俊,徐宁.ShineRoar探针技术检测单核苷酸多态性[J].中华检验医学杂志,2007,30(6):609-612. 被引量:8
  • 5Suckling KE,Macphee CH. Lipoprotein-associated phospholipase A2:a target directed at the atherosclerotic plaque. Expert opinion on therapeutic targets, 2002,6 : 309 -314.
  • 6Oei HH, van der Meer IM, Hofman A, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke : the Rotterdam Study. Circulation,2005,111 : 570-575.
  • 7Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein-associated phos- pholipase A2 adds to risk prediction of incident coronary events by C- reactive protein in apparently healthy middle-aged men from the general population:results from the 14-year follow-up of a large cohort from southern Germany. Circulation, 2004,110 : 1903-1908.
  • 8Abuzeid AM, Hawe E, Humphries SE, et al. Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis ,2003,168:283-288.
  • 9Jang Y,Kim OY,Koh SJ,et al. The Val279Phe variant of the lipopro- tein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men. The Journal of clinical endocrinology and metabolism ,2006,91:3521-3527.
  • 10Sutton BS, Crosslin DR, Shah SH, et al. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Human molecular genetics, 2008,17 : 1318-1328.

二级参考文献20

  • 1Rudi K, Holck AL. Real-time closed tube single nucleotide polymorphism (SNP) quantitlcation in pooled samples by quencher extension ( QEXT ). Nucleic Acids Res, 2003,31 : e117.
  • 2Sollnas A, Brown I.J, McKeen C, et al. Duplex Scorpion primers in SNP analysis and FRET applications. Nucleic Acids Res, 2001,29 : E96.
  • 3Rao KV, Stevens PW, Hall JG, et al. C, enotyping single nucleotide polymorphisms directly from genomlc DNA by invasive cleavage reaction on microspheres. Nucleic Acids Res, 2003, 31 : e66.
  • 4Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res, 1998,8 : 1229-1231.
  • 5Carlson CS, Newman TL, Nickerson DA. SNPing in the human genome. Curr Opin Chem Biol, 2001,5:78-85.
  • 6Ergen E, Weber M, Jacob J, et al. Twin probes as a novel tool for the detection of single-nucleotide polymorphisms. Chemistry, 2006,12:3707-3713.
  • 7Beltinger CP, White PS, Maris JM, et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics, 1996, 35:94-100.
  • 8Komata T, Tsuchiya N,. Matsushita M, et al. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens, 1999,53:527-533.
  • 9Barton A, John S, Oilier WE, et al. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor Ⅱ, but not tumor necrosis factor receptor Ⅰ, in Caucasians. Arthritis Rheum, 2001,44:61-65.
  • 10Xu N, Dahlback B. A novel human apolipoprotein ( apoM ). J Biol Chem, 1999, 274:31286-31290.

共引文献7

同被引文献95

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部